uMotif

The London-based company most recently raised £5 million in Series A funding in 2020.

The funding will also help get much-needed therapies to patients faster. 

Patient-facing clinical trial software company uMotif has raised $3.

People with Parkinson’s disease who used an app to track and manage symptom improved their medication adherence and had better conversations with clinicians about their condition, according to the results of a recent National Health Services study published in the journal Nature Parkinson’s.